Comparison of Next-Generation Sequencing Panels and Platforms for Detection and Verification of Somatic Tumor Variants for Clinical Diagnostics

Journal of Molecular Diagnostics

Volumn 18, Issue 6, 2016, Pages 842-850

  Misyura, Maksym ^a   Zhang, Tong ^a   Sukhai, Mahadeo A ^a   Thomas, Mariam ^a   Garg, Swati ^a   Kamel Reid, Suzanne ^a,b,c   Stockley, Tracy L ^a,b,c  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; TUMOR MARKER;

ARTICLE; CANCER DIAGNOSIS; CLINICAL LABORATORY; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DNA EXTRACTION; GENE FREQUENCY; GENETIC ANALYZER; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN GENOME; HUMAN TISSUE; MAJOR CLINICAL STUDY; MOLECULAR DIAGNOSIS; MOLECULAR DIAGNOSTICS; NEXT GENERATION SEQUENCING; POLYMERASE CHAIN REACTION SYSTEM; RETROSPECTIVE STUDY; SOFTWARE; SOLID TUMOR; ALLELE; GENETIC SCREENING; GENETIC VARIATION; GENETICS; HIGH THROUGHPUT SEQUENCING; NEOPLASMS; PROCEDURES; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; STANDARDS; WORKFLOW;

ALLELES; BIOMARKERS, TUMOR; GENE FREQUENCY; GENETIC TESTING; GENETIC VARIATION; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; NEOPLASMS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; WORKFLOW;

EID: 84992518910     PISSN: 15251578     EISSN: 19437811     Source Type: Journal    
DOI: 10.1016/j.jmoldx.2016.06.004     Document Type: Article

References (27)

1. 1 Meldrum, C., Doyle, M.A., Tothill, R.W., Next-generation sequencing for cancer diagnostics: a practical perspective. Clin Biochem Rev, 32, 2011, 177.
2. 2 Cree, I.A., Deans, Z., Ligtenberg, M.J.L., Normanno, N., Edsjö, A., Rouleau, E., Solé, F., Thunnissen, E., Timens, W., Schuuring, E., Dequeker, E., Murray, S., Dietel, M., Groenen, P., Van Krieken, J.H., European Society of Pathology Task Force on Quality Assurance in Molecular Pathology, Royal College of Pathologists. Guidance for laboratories performing molecular pathology for cancer patients. J Clin Pathol 67 (2014), 923–931.
3. 3 Simon, R., Roychowdhury, S., Implementing personalized cancer genomics in clinical trials. Nat Rev Drug Discov 12 (2013), 358–369.
4. 4 Kizys, M.M., Cardoso, M.G., Lindsey, S.C., Harada, M.Y., Soares, F.A., Melo, M.C.C., Montoya, M.Z., Kasamatsu, T.S., Kunii, I.S., Giannocco, G., Optimizing nucleic acid extraction from thyroid fine-needle aspiration cells in stained slides, formalin-fixed/paraffin-embedded tissues, and long-term stored blood samples. Arq Bras Endocrinol Metabol 56 (2012), 618–626.
5. 5 Bennett, N.C., Farah, C.S., Next-generation sequencing in clinical oncology: next steps towards clinical validation. Cancers 6 (2014), 2296–2312.
6. 6 Ulahannan, D., Kovac, M., Mulholland, P., Cazier, J., Tomlinson, I., Technical and implementation issues in using next-generation sequencing of cancers in clinical practice. Br J Cancer 109 (2013), 827–835.
7. 7 Ding, L., Ley, T.J., Larson, D.E., Miller, C.A., Koboldt, D.C., Welch, J.S., Ritchey, J.K., Young, M.A., Lamprecht, T., McLellan, M.D., Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing. Nature 481 (2012), 506–510.
8. 8 Ding, L., Wendl, M.C., McMichael, J.F., Raphael, B.J., Expanding the computational toolbox for mining cancer genomes. Nat Rev Genet 15 (2014), 556–570.
9. 9 Mardis, E.R., Next-generation sequencing platforms. Annu Rev Anal Chem 6 (2013), 287–303.
10. 10 Team, R.C., R: A Language and Environment for Statistical Computing. 2012, R Foundation for Statistical Computing, Vienna, Austria: ISBN 3-900051-07-0, 2014.
11. 11 Martin Bland, J., Altman, D., Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 327 (1986), 307–310.
12. 12 Newton, C., Graham, A., Heptinstall, L., Powell, S., Summers, C., Kalsheker, N., Smith, J., Markham, A., Analysis of any point mutation in DNA: the amplification refractory mutation system (ARMS). Nucleic Acids Res 17 (1989), 2503–2516.
13. 13 Lievre, A., Bachet, J.B., Le Corre, D., Boige, V., Landi, B., Emile, J.F., Côté, J.F., Tomasic, G., Penna, C., Ducreux, M., KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer. Cancer Res 66 (2006), 3992–3995.
14. 14 Thomas, R.K., Baker, A.C., DeBiasi, R.M., Winckler, W., LaFramboise, T., Lin, W.M., et al. High-throughput oncogene mutation profiling in human cancer. Nat Genet 39 (2007), 347–351.
15. 15 Bland, J.M., Altman, D.G., Comparing methods of measurement: why plotting difference against standard method is misleading. Lancet 346 (1995), 1085–1087.
16. 16 Sukhai, M.A., Craddock, K.J., Thomas, M., Hansen, A.R., Zhang, T., Siu, L., Bedard, P., Stockley, T.L., Kamel-Reid, S., A classification system for clinical relevance of somatic variants identified in molecular profiling of cancer. Genet Med 18 (2016), 128–136.
17. 17 Tsiatis, A.C., Norris-Kirby, A., Rich, R.G., Hafez, M.J., Gocke, C.D., Eshleman, J.R., Murphy, K.M., Comparison of Sanger sequencing, pyrosequencing, and melting curve analysis for the detection of KRAS mutations: diagnostic and clinical implications. J Mol Diagn 12 (2010), 425–432.
18. 18 Singh, R.R., Patel, K.P., Routbort, M.J., Reddy, N.G., Barkoh, B.A., Handal, B., Kanagal-Shamanna, R., Greaves, W.O., Medeiros, J., Aldape, K.D., Luthra, R., Clinical validation of a next-generation sequencing screen for mutational hotspots in 46 cancer-related genes. J Mol Diagn 15 (2013), 607–622.
19. 19 Gleeson, F.C., Kipp, B.R., Kerr, S.E., Voss, J.S., Graham, R.P., Campion, M.B., Minot, D.M., Tu, Z.J., Klee, E.W., Lazaridis, K.N., Kinase genotype analysis of gastric gastrointestinal stromal tumor cytology samples using targeted next-generation sequencing. Clin Gastroenterol Hepatol 13 (2015), 202–206.
20. 20 Choffnes, E.R., Sparling, P.F., Hamburg, M.A., Lemon, S.M., Mack, A., Global Infectious Disease Surveillance and Detection: Assessing the Challenges–Finding Solutions, Workshop Summary. 2007, National Academies Press, Washington, DC.
21. 21 Walter, M.J., Shen, D., Ding, L., Shao, J., Koboldt, D.C., Chen, K., Larson, D.E., McLellan, M.D., Dooling, D., Abbott, R., Fulton, R., Magrini, V., Schmidt, H., Kalicki-Veizer, J., O'Laughlin, M., Fan, X., Grillot, M., Witowski, S., Heath, S., Frater, J.L., Eades, W., Tomasson, M., Westervelt, P., DiPersio, J.F., Link, D.C., Mardis, E.R., Ley, T.J., Wilson, R.K., Graubert, T.A., Clonal architecture of secondary acute myeloid leukemia. N Engl J Med 366 (2012), 1090–1098.
22. 22 Park, S.Y., Gönen, M., Kim, H.J., Michor, F., Polyak, K., Cellular and genetic diversity in the progression of in situ human breast carcinomas to an invasive phenotype. J Clin Invest 120 (2010), 636–644.
23. 23 Loman, N.J., Misra, R.V., Dallman, T.J., Constantinidou, C., Gharbia, S.E., Wain, J., Pallen, M.J., Performance comparison of benchtop high-throughput sequencing platforms. Nat Biotechnol 30 (2012), 434–439.
24. 24 Quail, M.A., Smith, M., Coupland, P., Otto, T.D., Harris, S.R., Connor, T.R., Bertoni, A., Swerdlow, H.P., Gu, Y., A tale of three next generation sequencing platforms: comparison of Ion Torrent, Pacific Biosciences and Illumina MiSeq sequencers. BMC Genomics, 13, 2012, 341.
25. 25 Boland, J., Chung, C., Roberson, D., Mitchell, J., Zhang, X., Im, K., He, J., Chanock, S., Yeager, M., Dean, M., The new sequencer on the block: comparison of Life Technology's Proton sequencer to an Illumina HiSeq for whole-exome sequencing. Hum Genet 132 (2013), 1153–1163.
26. 26 Chen, S., Li, S., Xie, W., Li, X., Zhang, C., Jiang, H., Zheng, J., Pan, X., Zheng, H., Liu, J.S., Performance comparison between rapid sequencing platforms for ultra-low coverage sequencing strategy. PLoS One, 9, 2014, e92192.
27. 27 Jeon, Y.J., Zhou, Y., Li, Y., Guo, Q., Chen, J., Quan, S., Zhang, A., Zheng, H., Zhu, X., Lin, J., The feasibility study of non-invasive fetal trisomy 18 and 21 detection with semiconductor sequencing platform. PLoS One, 9, 2014, e110240.